Swift Biosciences Unveils qPCR Primer Tech; Hopes to Market First Product by Year's End | GenomeWeb

This article was originally published on Feb. 23.

By Ben Butkus

Swift Biosciences, a year-old startup developing molecular biology reagents for research and diagnostics, emerged from stealth mode this week by publicly presenting the first research results for its core technology, a new kind of highly sensitive qPCR primer designed for mutation and low copy number detection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.